Bio-Rad Laboratories
(BIO)Financial Overview
About Bio-Rad Laboratories
Bio-Rad Laboratories, with CEO Norman Schwartz, provides life science research and clinical diagnostics tools used in laboratories worldwide. Its technologies include PCR, imaging, and cell biology platforms. Schwartz has led the company through digital upgrades and life sciences expansion. Bio-Rad supports genomic research, diagnostics, and academic institutions. It is a trusted name in lab innovation.
Analyst Forecast
Bio-Rad combines life-science tools, clinical diagnostics and a valuable equity interest, but operating growth has remained uneven. Academic and biopharma capital spending can weaken in recession, while diagnostics provide stability. Product execution, cost discipline and clearer capital allocation are needed. The low operating momentum makes a broad research recovery more important than balance-sheet optionality alone.
Analysis by Luigi Wewege
President at Caye International Bank
Luigi Wewege is President of the award-winning Caye International Bank. He is the author of The Digital Banking Revolution, now in its third edition, and of the article “Disruptions and Digital Banking Trends,” published in The Journal of Applied Finance & Banking. Luigi has also co-authored economic research examining the accuracy of credit bureau data, which was presented before the United States Congress. At Caye Bank, his research and strategic insights help guide billions in client portfolio decisions across international markets. Known for his disciplined diversification philosophy, he served as the conceptual architect behind this Portfolio Fit Calculator. He holds an Italian MBA specializing in International Business, and earned his BSBA with a triple major in Finance, International Business, and Management, graduating with Latin Honors from the University of Missouri–St. Louis.
18 years of experience
Should You Buy Bio-Rad Laboratories Stock?
This interactive tool helps you determine whether this stock fits into your investment strategy based on your portfolio size, risk tolerance, and allocation preferences.
What this calculator analyzes:
- Risk compatibility between your profile and this stock
- Appropriate allocation size for your portfolio
- Diversification recommendations
- P/E ratio context and valuation analysis
⚠️ This tool is for informational purposes only. It does not constitute financial advice. Investing involves risk, including loss of capital. Always consult a licensed financial advisor before making investment decisions.